Trials / Completed
CompletedNCT03911427
Oat and Cholesterol
Impact of Oat Product on LDL Cholesterol in Healthy Men and Women With Elevated LDL-cholesterol
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 207 (actual)
- Sponsor
- PepsiCo Global R&D · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The primary objective is to assess the effect of an oat ingredient provided over 4 weeks on serum LDL cholesterol in men and women with elevated LDL-cholesterol compared to a placebo. Secondary endpoints are fasting serum total- and HDL-cholesterol, non-HDL-cholesterol, triglycerides, glucose, insulin, glycated albumin, HOMA-IR and Framingham risk score
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Active oat beverage | Powder packaged in sachets, mixed with water and consumed 3 times per day for 1 month |
| OTHER | Control rice beverage | Powder packaged in sachets, mixed with water and consumed 3 times per day for 1 month |
Timeline
- Start date
- 2019-04-10
- Primary completion
- 2020-02-20
- Completion
- 2020-02-28
- First posted
- 2019-04-11
- Last updated
- 2020-03-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03911427. Inclusion in this directory is not an endorsement.